JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendoza-Fernández, V.
Right arrow Articles by Barajas-López, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendoza-Fernández, V.
Right arrow Articles by Barajas-López, C.

Vol. 293, Issue 1, 172-179, April 2000

ATP Inhibits Glutamate Synaptic Release by Acting at P2Y Receptors in Pyramidal Neurons of Hippocampal Slices1

Victor Mendoza-Fernández, R. David Andrew and Carlos Barajas-López

Department of Anatomy and Cell Biology, Queen's University, Kingston, Ontario, Canada

It has been proposed that extracellular ATP inhibits synaptic release of glutamate from hippocampal CA1 synapses after its catabolism to adenosine. We investigated the possibility that at least part of this effect is mediated by ATP itself acting on P2Y receptors. ATP and various analogs decreased the amplitude and duration of glutamate-mediated excitatory postsynaptic potentials in all tested neurons. This effect was reversible and concentration-dependent and had the following rank order of agonist potency: AMP = ATP = adenosine-5'-O-(3-thio)triphosphate > adenosine = ADP. alpha ,beta -Methylene ATP, beta ,gamma -methylene ATP, 2-methylthioadenosine 5'-triphosphate, GTP, and UTP induced only a partial response. The depolarization induced by exogenous glutamate was not affected by ATP, indicating that this nucleotide acts presynaptically to inhibit glutamate-mediated excitatory postsynaptic potentials. Neither inhibition of ectonucleotidase activity with alpha ,beta -methylene ADP, suramin, or pyridaxalphosphate-6-azophenyl-2',4'-disulfonic acid 4-sodium nor removal of extracellular adenosine (with adenosine deaminase) altered ATP effects. 8-Cyclopentyltheophylline competitively inhibited ATP effects, whereas P2 receptor antagonists (pyridaxalphosphate-6-azophenyl-2',4'-disulfonic acid 4-sodium, suramin, and reactive blue 2) were ineffective. ATP effects were by far more sensitive to pertussis toxin (PTX) than those of adenosine. After PTX, adenosine-5'-O-(3-thio)triphosphate induced only a partial response, and ATP concentration-response curve was biphasic. The second phase of this curve was blocked by adenosine deaminase, implying that it is mediated by adenosine as a result of ATP catabolism. Under control conditions, however, catabolism of ATP is not required to explain its actions. In conclusion, ATP inhibits synaptic release of glutamate by direct activation of P2Y receptors that are PTX- and 8-cyclopentyltheophylline-sensitive.


1 This work was supported by the Medical Research Council of Canada. C.B.-L. was supported in part by the Ontario Ministry of Health (Career Scientist Award 04500).


0022-3565/00/2931-0172$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Melnik, M. Wright, J. A. Tanner, T. Tsintsadze, V. Tsintsadze, A. D. Miller, and N. Lozovaya
Diadenosine Polyphosphate Analog Controls Postsynaptic Excitation in CA3-CA1 Synapses via a Nitric Oxide-Dependent Mechanism
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 579 - 588.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. Casel, J. Brockhaus, and J. W Deitmer
Enhancement of spontaneous synaptic activity in rat Purkinje neurones by ATP during development
J. Physiol., October 1, 2005; 568(1): 111 - 122.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. J. Rodrigues, T. Almeida, P. J. Richardson, C. R. Oliveira, and R. A. Cunha
Dual Presynaptic Control by ATP of Glutamate Release via Facilitatory P2X1, P2X2/3, and P2X3 and Inhibitory P2Y1, P2Y2, and/or P2Y4 Receptors in the Rat Hippocampus
J. Neurosci., July 6, 2005; 25(27): 6286 - 6295.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
V. F Safiulina, A. M Kasyanov, E. Sokolova, E. Cherubini, and R. Giniatullin
ATP contributes to the generation of network-driven giant depolarizing potentials in the neonatal rat hippocampus
J. Physiol., June 15, 2005; 565(3): 981 - 992.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Saitow, T. Murakoshi, H. Suzuki, and S. Konishi
Metabotropic P2Y Purinoceptor-Mediated Presynaptic and Postsynaptic Enhancement of Cerebellar GABAergic Transmission
J. Neurosci., February 23, 2005; 25(8): 2108 - 2116.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Kawamura, C. Gachet, K. Inoue, and F. Kato
Direct Excitation of Inhibitory Interneurons by Extracellular ATP Mediated by P2Y1 Receptors in the Hippocampal Slice
J. Neurosci., December 1, 2004; 24(48): 10835 - 10845.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Koizumi, K. Fujishita, M. Tsuda, Y. Shigemoto-Mogami, and K. Inoue
Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures
PNAS, September 16, 2003; 100(19): 11023 - 11028.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. F. Agnati, S. Ferre, C. Lluis, R. Franco, and K. Fuxe
Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons
Pharmacol. Rev., September 1, 2003; 55(3): 509 - 550.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Ortinau, B. Laube, and H. Zimmermann
ATP Inhibits NMDA Receptors after Heterologous Expression and in Cultured Hippocampal Neurons and Attenuates NMDA-Mediated Neurotoxicity
J. Neurosci., June 15, 2003; 23(12): 4996 - 5003.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. A. Masino, L. Diao, P. Illes, N. R. Zahniser, G. A. Larson, B. Johansson, B. B. Fredholm, and T. V. Dunwiddie
Modulation of Hippocampal Glutamatergic Transmission by ATP Is Dependent on Adenosine A1 Receptors
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 356 - 363.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Matsuoka, S. Ohkubo, J. Kimura, and Y. Uezono
Adenine Nucleotide-Induced Activation of Adenosine A2B Receptors Expressed in Xenopus laevis Oocytes: Involvement of a Rapid and Localized Adenosine Formation by Ectonucleotidases
Mol. Pharmacol., March 1, 2002; 61(3): 606 - 613.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Yoshioka, O. Saitoh, and H. Nakata
Heteromeric association creates a P2Y-like adenosine receptor
PNAS, May 30, 2001; (2001) 121587098.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. B. Miles, M. A. Parkis, J. Lipski, and G. D. Funk
Modulation of phrenic motoneuron excitability by ATP: consequences for respiratory-related output in vitro
J Appl Physiol, May 1, 2002; 92(5): 1899 - 1910.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Yoshioka, O. Saitoh, and H. Nakata
Heteromeric association creates a P2Y-like adenosine receptor
PNAS, June 19, 2001; 98(13): 7617 - 7622.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.